Hypoparathyroidism

Thursday, May 12, 2022

2:10 PM – 2:30 PM

Location: Breakout Room 4-Aqua ABC (Level 3)

Speaker(s)

Bart Clarke, MD
Professor of Medicine, Mayo Clinic College of Medicine
Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic
Rochester, Minnesota, United States

Disclosure: Ascendis, Inc. (Self) : Research Grant (Status: Ongoing); Bristol Myers Squibb (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Data Monitoring Committee (Status: Ongoing); Chugai Pharmaceuticals (Self) : Research Grant (Status: Terminated --- 7/1/2021); Takeda (Self) : Research Grant (Status: Ongoing)

PDF Slides

Learning Objectives:

Review the diagnosis of hypoparathyroidism
Discuss recent advances in the epidemiology of hypoparathyroidism
Identify recent and coming advances in management of hypoparathyroidism

Participants should be aware of the following financial/non-financial relationships:

Bart Clarke, MD: Ascendis, Inc. (Individual(s) Involved: Self): Research Grant; Bristol Myers Squibb (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Data Monitoring Committee; Chugai Pharmaceuticals (Individual(s) Involved: Self): Research Grant; Takeda (Individual(s) Involved: Self): Research Grant